Page last updated: 2024-08-21

cepharanthine and Esophageal Squamous Cell Carcinoma

cepharanthine has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, Q; Chen, P; Feng, Y; Li, Z; Liu, H; Su, G; Wang, X; Wang, Y; Xu, D; Zhang, R; Zhou, P1

Other Studies

1 other study(ies) available for cepharanthine and Esophageal Squamous Cell Carcinoma

ArticleYear
Cepharanthine Hydrochloride Improves Cisplatin Chemotherapy and Enhances Immunity by Regulating Intestinal Microbes in Mice.
    Frontiers in cellular and infection microbiology, 2019, Volume: 9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bacteria; Benzylisoquinolines; Cell Line, Tumor; Cisplatin; Disease Models, Animal; DNA, Ribosomal; Drug Synergism; Drug Therapy; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Gastrointestinal Microbiome; Humans; Immunity; Immunity, Innate; Intestinal Mucosa; Metagenomics; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid Differentiation Factor 88; Signal Transduction; Toll-Like Receptor 4; Xenograft Model Antitumor Assays

2019